Tenofovir DF

Fidelia Bernice, Pharm.D., BCIDP
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

FDA

  1. Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
  2. Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg

NON-FDA APPROVED USES

  • Treatment of hepatitis in HIV-HBV co-infected pts.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: January 14, 2021